The US is the leader in the global medical device industry. As per the International Trade Administration, the US generated a revenue of $156 billion in 2017, which accounted for 40% of the global medical device industry. The US medical device companies are renowned globally owing to their high technology and innovative products. Even though the country has a significant share in medical device, it is currently facing a shortage of essential medical equipment amid COVID-19 outbreak. The coronavirus cases in the US surpassed 100,000 and thereby healthcare facilities have been reported an increasing need for more medical equipment to provide better care to the COVID-19 patients. Among medical equipment, there is a remarkable demand for ventilators to provide breathing support to the COVID-19 patients, as the major symptom of the condition is breathing problem.  

The US government is working closely to meet the demand for ventilators and asked ventilator manufacturers to expand their ventilators production capacity. In March 2020, the US Food and Drug Administration (FDA) has taken action to support enhance the ventilators supply, ventilator accessories, ventilator tubing connectors, as well as filtering facepiece respirators (FFRs) due to COVID-19. The US FDA issued an Emergency Use Authorization (EUA) for supporting the emergency use of certain ventilators, positive pressure breathing devices, and anesthesia gas machines modified for use as ventilators in health care settings, anesthesia gas machines modified for use as ventilators.

The EUA demonstrated the FDA’s ability to adapt and react faster during the epidemic by offering higher flexibility in regulations and enabling to raise the inventory for the US ventilator. This, in turn, will allow patients with COVID-19 to have access to lifesaving devices which is urgently required. On 25th March 2020, Prisma Health received EUA from the US FDA for its VESper ventilator expansion device. This device will enable to increase the capacity of the ventilator for COVID-19 patients. This advanced ventilator expansion device enables healthcare setting to treat up to four patients using a single ventilator. 3D printing technology is used for the development of this device and is produced with already available materials for use in medical devices. This action will support to meet the increasing demand for ventilators in the country and thereby will support to increase delivery of effective treatment to the COVID-19 patients.

The study on the effect of COVID-19 on the US ventilator industry is segmented into portable and intensive care ventilators. Portable ventilators are being significantly adopted for the treatment of respiratory conditions. Portable ventilators are normally utilized by patients who require breathing support for the long-term. These are compact and lightweight and provides certain similar features that earlier was available only on expensive intensive care ventilators. Several companies are working towards increasing production of portable ventilators, as per the government orders. For instance, on 24th March 2020, ZOLL Medical Corp. declared that it is taking aggressive steps to expand the production capacity to 10,000 ventilators every month amid COVID-19 epidemic. This shows nearly a 25-fold expansion from earlier production volumes. The company builds portable ventilators for use in challenging healthcare environments. It has reached out to its supply base and a large number of which is in the US, to join their support in meeting the demand.

The major companies supplying ventilators to the US for the treatment of patients with COVID-19 include General Electric Co., ZOLL Medical Corp., Ford Motors Co., Ventec Life Systems, Inc., ResMed Corp., and Hill-Rom Holdings, Inc. These companies are partnering to expand their production limit of ventilators to cope up with the continuously increasing demand. For instance, on 24th March 2020, Ford declared to work with General Electric, UAW, and 3M to accelerate the production of respiratory equipment to healthcare professionals due to coronavirus pandemic. The company will work with 3M to produce powered air-purifying respirators (PAPRs) at scale. 3M and Ford are partnering regarding a new design leveraging components from both companies to fulfill the emergency need for health care workers. Additionally, GE Healthcare and Ford are collaborated to leverage production of a streamlined version of GE Healthcare’s current ventilator design to help patients from difficulty in breathing or respiratory failure.

Research Methodology

OMR global recently published a report addressing the impact of COVID-19 on the US ventilator industry. The study is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, laws and policies, consumer behavior and macro-economic factors. Besides, an expected recovery timeline of the industry will also be included with the best- and worst-case scenario which will aid clients to take their future steps in the decision-making process.

Sources Include

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog
• Government Organizations Reports

The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

The Report Covers

• Comprehensive research methodology of the pre and post-COVID-19 impact on the US ventilator industry.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US ventilator industry.
• Insights about market determinants which are stimulating the US ventilator industry.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.